【摘要】 目的:验证万拉法新治疗广泛性焦虑的疗效及不良反应。方法:68例广泛性焦虑症按就医顺序分为两组,分别用万拉法新及阿普唑仑进行治疗,疗程6周,于治疗前及治疗后第1、2、4、6周末进行汉密顿焦虑量表(HAMA)、焦虑自评量表(SAS)、副反应量表(TESS)评定疗效及不良反应。结果:万拉法新和阿普唑仑两药疗效相仿,万拉法新不良反应少而轻微。结论:万拉法新是治疗广泛性焦虑症较为理想的药物。更多还原

【Abstract】 Objective:To verify the clinical efficacy and the side effects of venlafaxine in the treatment of general anxiety disorder. Methods:68 patients were assigned to velafaxine group and alprazolam group respectively for 6 weeks.The efficacy and side effects were evaluated by HAMA,SAS and TESS before and after 1,2,3,4 and 6 weeks.Results: The efficacy of venlafaxine and alprazolam had no significant difference,but venlafaxine had fewer side effects.Conclusions: Venlafaxine is an effective and safe medicine in the treatment of general anxiety disorder.更多还原